 |
|
|
|
|
Triglyceride-Rich Lipoproteins
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
| 13 |
 |
|
|
Incidence of coronary heart disease-induced events
|
|
|
|
|
|
[ Table ] |
|
|
|
|
| 14 |
|
|
|
Risk factors associated with plasma triglycerides
|
|
|
|
|
|
[ Table ] |
|
|
|
|
| 15 |
|
|
|
Risk of CHD with increasing triglycerides
|
|
|
|
|
|
[ Table ] |
|
|
|
|
| 16 |
|
|
|
Defining hypertriglyceridaemia
|
|
|
|
|
|
[ Table ] |
|
|
|
|
| 17 |
|
|
|
Metabolic disorders associated with plasma triglyceride elevations
|
|
|
|
|
|
[ Table ] |
|
|
|
|
| 18 |
|
|
|
Chemical substances that may elevate triglycerides
|
|
|
|
|
|
[ Table ] |
|
|
|
|
| 19 |
|
|
|
Triglyceride elevations and associated lipoprotein abnormalities
|
|
|
|
|
|
 |
|
|
|
|
| 20 |
|
|
|
Very-low-density lipoprotein metabolism
|
|
|
|
|